Powerbone Dental Putty is widely used for sinus lift augmentation due to its viscoelastic form-stable consistency, no-prep syringe delivery, and membrane-free clinical protocol. In human histology studies, it has demonstrated 40–50% new bone formation at 12–16 weeks — exceeding xenograft and allograft benchmarks. 

Yes. Powerbone’s viscoelastic putty formulation is form-stable on placement, eliminating micromovement that slows healing. In the majority of clinical indications — including sinus lift, socket preservation, and peri-implant defects — no separate GBR membrane is required.

Both are synthetic putty bone grafts with a membrane-free clinical protocol. Powerbone contains silicate-substituted β-TCP and has human histology data demonstrating 40–50% new bone at 12–16 weeks. It is supplied ready-to-use in an ergonomic syringe with no mixing required.

Standard β-TCP (beta-tricalcium phosphate) is a widely used synthetic bone graft. Silicate substitution enhances osteogenic activity, making it equivalent to autograft in clinical studies and superior to standard β-TCP in terms of new bone formation rate and quality.

Yes. Powerbone contains no hydroxyapatite, which is the component that makes many synthetic grafts non-resorbable or very slow to resorb. Powerbone resorbs in a timeframe closely matched to natural bone remodelling.